U.S. Supreme Court Allows Continued Telehealth Access to Abortion Pill Amid Legal Dispute
The U.S. Supreme Court has decided to maintain access to the abortion pill mifepristone through telehealth services, despite a pending legal challenge. This decision overturns a previous ruling by the 5th U.S. Circuit Court of Appeals, which had reinstated requirements for in-person dispensing of the medication. The FDA had initially relaxed these requirements during the Biden administration, citing the COVID-19 pandemic as a reason to allow mail delivery of the drug following telehealth consultations. The Supreme Court's unsigned order allows the lawsuit to proceed in lower courts, with Justices Samuel Alito and Clarence Thomas dissenting. The ruling has sparked reactions from various organizations, with some expressing relief over the continued access to what they consider essential healthcare, while others voice concerns about the safety and potential misuse of the medication. 
